Description

Ozagrel Sodium is a selective thromboxane A2 (TXA2) synthase inhibitor, a key pharmaceutical intermediate and active ingredient. Its primary value lies in its potent antiplatelet and vasodilatory effects, making it crucial for research and development in cardiovascular and cerebrovascular therapeutics. This compound is essential for pharmaceutical manufacturers, R&D laboratories, and academic institutions focused on developing treatments for thrombosis, ischemic stroke, and related conditions.

Application

• Pharmaceutical Active Ingredient (API): Primary use as the active component in antiplatelet and antithrombotic medications.
• Cardiovascular Research: Critical for in-vitro and in-vivo studies targeting thromboxane A2 pathways, platelet aggregation, and vasoconstriction.
• Cerebrovascular Drug Development: Used in R&D for novel treatments of ischemic stroke and transient ischemic attacks (TIAs).
• Reference Standard: Serves as a high-purity analytical standard for quality control and method development in pharmaceutical analysis.
• Preclinical & Clinical Trial Material: Supplied as GMP-grade material for non-clinical safety studies and clinical trial manufacturing.
• Biochemical Pathway Inhibition Studies: Utilized in pharmacological research to study the arachidonic acid cascade and its role in inflammation and hemostasis.

Basic Information

Product Name	Ozagrel Sodium
CAS No.	189224-26-8
Molecular Formula	C13H11N2NaO2
Molecular Weight	250.23 g/mol
Synonyms	Ozagrel Sodium Salt; (E)-3-[4-(1H-Imidazol-1-ylmethyl)phenyl]-2-propenoic Acid Sodium Salt; OKY-046 Sodium; Sodium (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]acrylate; Cataclot; Xanbon; 189224-26-8; OKY 046 Sodium
EINECS	Contact for details

Quality Control

Our Ozagrel Sodium is manufactured under strict quality management systems. We offer material compliant with current Good Manufacturing Practice (cGMP) principles for pharmaceutical applications. Every batch undergoes comprehensive analytical testing, including identification, purity assay, and impurity profiling via HPLC, to ensure it meets stringent pharmacopeial standards. A detailed Certificate of Analysis (COA) is provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and must be kept under dry, inert conditions to maintain stability and potency. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥98.5% (on anhydrous basis)
Water Content (KF)	≤2.0%
Residue on Ignition	≤0.1%
Heavy Metals	≤20 ppm
Related Substances (HPLC)	Total impurities ≤1.5% Any single impurity ≤0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.